New pulmonary arterial hypertension treatment offers hope for patients in advanced stage of disease: NEJM Dr. Kamal Kant Kohli12 Jun 2025 8:15 PM ISTA relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing...
Sotatercept Demonstrates Major Risk Reduction in Advanced PAH: ZENITH Trial Meghna A Singhania6 Jun 2025 5:33 PM ISTSotatercept significantly reduced the risk of all-cause mortality, lung transplantation, or ≥24-hour hospitalization for worsening pulmonary arterial...
FDA Approves Treprostinil Inhalation Powder to Expand Treatment for PAH and PH-ILD Dr. Kamal Kant Kohli26 May 2025 11:00 PM ISTThe US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog designed to enhance exercise...
Natco Pharma gets final approval for Bosentan tablets for oral suspension Ruchika Sharma10 Feb 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...
Merck to stop trial evaluating Winrevair early in pulmonary arterial hypertension Ruchika Sharma31 Jan 2025 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the Phase 3 HYPERION study evaluating WINREVAIR...
Novel PET approach may identify early signs of pulmonary arterial hypertension, highlights research Dr. Kamal Kant Kohli24 Jan 2025 7:30 AM ISTA new molecular imaging technique-18F-FAPI PET-can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH),...
Merck gets UK approval for lung disease drug Sotatercept Ruchika Sharma1 Jan 2025 3:13 PM ISTMerck has received approval from the UK's Medicines and Healthcare products Regulatory Agency for its therapy, sotatercept, to treat a rare lung...
ZENITH Trial Breakthrough: Winrevair Shows Significant Impact on Outcomes of Pulmonary Arterial Hypertension Medha Baranwal4 Dec 2024 8:00 PM ISTUSA: In patients with advanced pulmonary arterial hypertension (PAH), adding the biologic sotatercept-csrk (Winrevair; Merck) to the maximum tolerated...
Asporin Promising Protective Target in Pulmonary Arterial Hypertension Identifies New Multiomics Study Medha Baranwal18 Nov 2024 9:00 PM ISTUSA: A recent study published in the journal Circulation has revealed that the asporin gene could be a promising therapeutic target for patients with...
Rare Disease Show Episode 19: Decoding Pulmonary Arterial Hypertension with Dr Brajesh Kumar Mishra Dr. Nandita Mohan12 Nov 2024 9:15 PM ISTMedical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are medical conditions that...
Resistin Emerges as Key Predictor of Mortality and Disease Severity in Pulmonary Arterial Hypertension: Study Medha Baranwal31 July 2024 7:30 AM ISTUSA: Elevated levels of the cytokine resistin were strongly linked to a higher risk of mortality in adults with pulmonary arterial hypertension (PAH),...
Pulmonary arterial hypertension treatment: USFDA gives tentative nod to Alembic Pharma Selexipag for Injection Ruchika Sharma13 July 2024 1:30 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received tentative approval from the US Food & Drug...
